TORSELLO, ANTONIO BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 17.488
AS - Asia 9.408
EU - Europa 7.274
SA - Sud America 1.266
AF - Africa 230
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 16
Totale 35.700
Nazione #
US - Stati Uniti d'America 17.092
SG - Singapore 3.059
CN - Cina 2.026
VN - Vietnam 1.739
IT - Italia 1.543
HK - Hong Kong 1.165
DE - Germania 1.110
RU - Federazione Russa 1.039
BR - Brasile 950
SE - Svezia 681
IE - Irlanda 643
UA - Ucraina 633
GB - Regno Unito 413
IN - India 315
FR - Francia 302
CA - Canada 282
FI - Finlandia 250
AT - Austria 161
KR - Corea 139
BD - Bangladesh 134
ID - Indonesia 132
TR - Turchia 126
AR - Argentina 107
IQ - Iraq 104
NL - Olanda 89
ZA - Sudafrica 75
PL - Polonia 73
ES - Italia 69
MX - Messico 69
JP - Giappone 68
CO - Colombia 64
BE - Belgio 55
PK - Pakistan 55
SA - Arabia Saudita 54
DK - Danimarca 53
EC - Ecuador 49
PH - Filippine 43
CH - Svizzera 37
UZ - Uzbekistan 35
MY - Malesia 29
CL - Cile 26
KE - Kenya 26
BG - Bulgaria 25
MA - Marocco 25
TN - Tunisia 23
VE - Venezuela 23
NP - Nepal 19
CZ - Repubblica Ceca 18
EG - Egitto 18
LB - Libano 18
PY - Paraguay 16
JO - Giordania 15
TH - Thailandia 15
AU - Australia 14
EU - Europa 14
ET - Etiopia 13
IR - Iran 13
LT - Lituania 13
RO - Romania 13
OM - Oman 12
PE - Perù 12
PS - Palestinian Territory 12
TW - Taiwan 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
JM - Giamaica 11
IL - Israele 10
KZ - Kazakistan 10
AL - Albania 9
AZ - Azerbaigian 9
PT - Portogallo 9
CR - Costa Rica 8
DZ - Algeria 8
BO - Bolivia 7
HN - Honduras 7
HU - Ungheria 7
KG - Kirghizistan 7
SN - Senegal 7
EE - Estonia 6
NG - Nigeria 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
RS - Serbia 5
SC - Seychelles 5
GT - Guatemala 4
HR - Croazia 4
LY - Libia 4
NZ - Nuova Zelanda 4
GE - Georgia 3
MN - Mongolia 3
NI - Nicaragua 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CD - Congo 2
CM - Camerun 2
GA - Gabon 2
GH - Ghana 2
GR - Grecia 2
KH - Cambogia 2
Totale 35.664
Città #
Ann Arbor 2.635
Singapore 1.810
Ashburn 1.545
Woodbridge 1.350
Fairfield 1.171
Hong Kong 1.144
Houston 924
Chandler 917
Wilmington 834
San Jose 807
Frankfurt am Main 763
Dublin 612
Jacksonville 583
Seattle 557
Ho Chi Minh City 512
Milan 482
Hanoi 423
Beijing 399
New York 373
Cambridge 356
Dearborn 345
Santa Clara 277
Chicago 273
Princeton 260
Los Angeles 238
Dallas 237
Hefei 231
The Dalles 183
Nanjing 156
Vienna 140
Lauterbourg 129
Seoul 129
Lawrence 112
Helsinki 110
Shanghai 109
Council Bluffs 107
Jakarta 107
Moscow 106
Buffalo 102
Altamura 98
Lachine 97
São Paulo 96
Boardman 68
Da Nang 67
Guangzhou 64
London 64
Rome 62
Haiphong 61
San Diego 59
Detroit 57
Tokyo 52
Munich 51
Brussels 50
Toronto 50
Nanchang 48
Falls Church 47
Baghdad 44
Orem 43
Nuremberg 42
Kent 41
Warsaw 40
Pune 38
Rio de Janeiro 38
Andover 37
Hebei 37
Denver 36
Biên Hòa 34
Changsha 34
Tashkent 33
San Francisco 32
Fremont 31
Mountain View 31
Poplar 31
Shenyang 31
Grafing 30
Brooklyn 29
Dong Ket 29
Johannesburg 28
Stockholm 28
Atlanta 27
Huizen 27
Monza 26
Ha Long 25
Salt Lake City 25
Can Tho 24
Tianjin 24
Turku 24
Elora 23
Hải Dương 23
Jinan 23
Phoenix 23
Ankara 22
Hangzhou 22
Jiaxing 22
Philadelphia 22
Quận Bình Thạnh 22
Amsterdam 21
Chennai 21
Dhaka 21
Nairobi 21
Totale 23.924
Nome #
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 518
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 497
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 497
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 490
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 457
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 450
Growth hormone secretagogues and the regulation of calcium signaling in muscle 440
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 436
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 388
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 388
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 380
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 372
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 355
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 347
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 345
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 340
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 335
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 330
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 320
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 314
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 303
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 302
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 301
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 299
Feeding behavior during long-term hexarelin administration in young and old rats 294
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 294
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 294
Intrarticular cytokines and resolvin after ACL and meniscal tear in skeletally immature patients 290
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 288
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 285
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 282
Ghrelin in gastroenteric pathophysiology 281
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 281
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 281
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 279
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 278
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 274
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 273
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 270
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 269
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 268
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 267
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 266
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 265
TLQP-21 modulate inflammation and fibrosis in a model of ards 264
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 262
Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis 261
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 260
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 260
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 257
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 253
Ghrelin regulates proliferation and differentiation of osteoblastic cells. 253
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 252
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 247
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 246
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 245
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 245
Somatotropic dysregulation in old mammals 243
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 242
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 242
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 241
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 241
Somatostatin Withdrawal as Generator of Pulsatile GH Release in the Dog: A Possible Tool to Evaluate the Endogenous GHRH Tone? 240
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 239
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 239
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 238
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 238
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 236
Androgen therapy in neurodegenerative diseases 236
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 234
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 233
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 231
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 231
Progressive seizure aggravation in the repeated 6-Hz corneal stimulation model is accompanied by marked increase in hippocampal p-ERK1/2 immunoreactivity in neurons 230
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 227
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 225
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections? 224
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 223
Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy 222
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection 222
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 221
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results 219
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 219
Steroids and tissue-specific modulation of galanin gene expression in the male rat reproductive system 218
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 217
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 216
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 216
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 216
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 215
Growth hormone-inhibiting activity of cortistatin in the rat 214
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 213
Regulation of galanin by dexamethasone in the rat anterior pituitary and the uterus 213
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): recommendations from Italian scientific societies, patient associations and regulators 211
Farmacologia endocrina 211
Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat 211
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 210
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 209
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 208
Ghrelin expression in gut endocrine growths 208
Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic? 208
Totale 27.738
Categoria #
all - tutte 111.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 0 0 0 0 0 0 0 0 186 242
2021/20221.905 149 182 233 139 100 178 85 70 109 172 152 336
2022/20233.507 375 937 375 361 290 505 43 184 211 38 109 79
2023/20242.045 75 91 93 103 281 500 419 74 132 34 38 205
2024/20255.037 270 458 361 309 429 236 360 267 333 692 401 921
2025/202612.192 1.812 1.058 972 1.394 1.451 680 1.792 618 1.149 1.048 218 0
Totale 36.293